Bladder transitional cell carcinoma: Which Medications Cause It? (1,020 Reports Across 91 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Bladder transitional cell carcinoma has been reported as an adverse event with 91 different drugs in the FDA's FAERS database, with 1,020 total reports. 97 of these reports resulted in death.The drugs most commonly associated with Bladder transitional cell carcinoma are PIOGLITAZONE, ADALIMUMAB, and METHOTREXATE.
1,020
Total Reports
91
Drugs Involved
97
Deaths
312
Hospitalizations
66.3 yrs
Average Patient Age
22.8% / 77.2%
Female / Male
Which Drugs Cause Bladder transitional cell carcinoma Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| PIOGLITAZONE | 398 | 3.4% | 55 | 16 | 11 |
| ADALIMUMAB | 96 | 0.0% | 0 | 72 | 3 |
| METHOTREXATE | 95 | 0.0% | 10 | 77 | 4 |
| RITUXIMAB | 74 | 0.0% | 1 | 55 | 1 |
| TOCILIZUMAB | 68 | 0.1% | 0 | 62 | 0 |
| INFLIXIMAB | 63 | 0.0% | 0 | 53 | 2 |
| SULFASALAZINE | 55 | 0.1% | 3 | 51 | 0 |
| HYDROXYCHLOROQUINE | 50 | 0.1% | 0 | 46 | 0 |
| PREDNISONE | 48 | 0.0% | 3 | 18 | 9 |
| LENALIDOMIDE | 42 | 0.0% | 4 | 22 | 0 |
| RANITIDINE | 41 | 0.0% | 2 | 4 | 0 |
| TACROLIMUS | 39 | 0.0% | 1 | 7 | 7 |
| MYCOPHENOLATE MOFETIL | 37 | 0.1% | 1 | 5 | 7 |
| VALSARTAN | 35 | 0.2% | 0 | 27 | 2 |
| HYDROCHLOROTHIAZIDE\VALSARTAN | 32 | 0.5% | 0 | 26 | 0 |
| PREDNISOLONE | 32 | 0.0% | 3 | 29 | 0 |
| ETANERCEPT | 29 | 0.0% | 5 | 14 | 7 |
| LEVOTHYROXINE | 24 | 0.0% | 0 | 24 | 0 |
| AMPICILLIN | 23 | 0.6% | 0 | 23 | 0 |
| AZITHROMYCIN | 23 | 0.1% | 0 | 23 | 0 |